Results 131 to 140 of about 179,953 (145)
Some of the next articles are maybe not open access.

Predictive role of magnetic resonance imaging in the distinction of isocitrate dehydrogenase (IDH) mutant grade 4 astrocytomas versus glioblastomas

Acta Radiologica, 2023
Ahmet Mesrur Halefoglu   +2 more
exaly  

Isocitrate dehydrogenase mutations in gliomas: A review of current understanding and trials.

Neuro-Oncology Advances, 2023
Samuel K McBrayer   +2 more
exaly  

Isocitrate Dehydrogenase Mutant Grade II and III Glial Neoplasms

Hematology/Oncology Clinics of North America, 2022
Ingo K Mellinghoff, Kurt A Jaeckle
exaly  

Characterization of a mutation in the IDH-II subunit of the NAD-dependent isocitrate dehydrogenase from

Plant Science, 2004
David J Oliver
exaly  

Isocitrate dehydrogenase (IDH) inhibition as treatment of myeloid malignancies: Progress and future directions

Pharmacology & Therapeutics, 2017
Amir Fathi, Andrew M Brunner
exaly  

Prognosis and Clinicopathologic Features of Patients With Advanced Stage Isocitrate Dehydrogenase (IDH) Mutant and IDH Wild-Type Intrahepatic Cholangiocarcinoma

Oncologist, 2015
Hui Zheng, Andrew X Zhu, Theodore hong
exaly  

Diagnostic Features and 2-Hydroxyglutarate (2-HG) Levels Among Acute Myeloid Leukemia (AML) Patients with and without Isocitrate Dehydrogenase (IDH) Mutations

Blood, 2014
Adamia Sophia   +2 more
exaly  

Isocitrate dehydrogenase-mutant glioma: Evolving clinical and therapeutic implications

Cancer, 2017
Julie J Miller   +2 more
exaly  

Quantitation of isocitrate dehydrogenase (IDH)-induced and enantiomers of 2-hydroxyglutaric acid in biological fluids by a fully validated liquid tandem mass spectrometry method, suitable for clinical applications

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 2016
Véronique Saada   +2 more
exaly  

People also looked at

Frontiers in Oncology, 2019
Aram S Modrek   +2 more
exaly  
previous   12  13  14  15  

Home - About - Disclaimer - Privacy